A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux

被引:154
|
作者
Zhang, Shirley L. [1 ,2 ,3 ]
Yue, Zhifeng [2 ,3 ]
Arnold, Denice M. [2 ,3 ]
Artiushin, Gregory [2 ,3 ]
Sehgal, Amita [1 ,2 ,3 ]
机构
[1] Univ Penn, Perelman Sch Med, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Chronobiol Program Penn, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
关键词
P-GLYCOPROTEIN; ANTIEPILEPTIC DRUGS; DIURNAL-VARIATION; DROSOPHILA; BEHAVIOR; CELLS; GAP; INNEXINS; TRANSPORTERS; MECHANISMS;
D O I
10.1016/j.cell.2018.02.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endogenous circadian rhythms are thought to modulate responses to external factors, but mechanisms that confer time-of-day differences in organismal responses to environmental insults/therapeutic treatments are poorly understood. Using a xenobiotic, we find that permeability of the Drosophila "blood''-brain barrier (BBB) is higher at night. The permeability rhythm is driven by circadian regulation of efflux and depends on a molecular clock in the perineurial glia of the BBB, although efflux transporters are restricted to subperineurial glia (SPG). We show that transmission of circadian signals across the layers requires cyclically expressed gap junctions. Specifically, during nighttime, gap junctions reduce intracellular magnesium ([Mg2+]i), a positive regulator of efflux, in SPG. Consistent with lower nighttime efflux, nighttime administration of the anti-epileptic phenytoin is more effective at treating a Drosophila seizure model. These findings identify a novel mechanism of circadian regulation and have therapeutic implications for drugs targeted to the central nervous system.
引用
收藏
页码:130 / +
页数:20
相关论文
共 50 条
  • [21] Antibody blood-brain barrier efflux is modulated by glycan modification
    Finke, John M.
    Ayres, Kari R.
    Brisbin, Ryan P.
    Hill, Half A.
    Wing, Emily E.
    Banks, William A.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (09): : 2228 - 2239
  • [22] Pharmacokinetic consequences of active drug efflux at the blood-brain barrier
    Syvänen, S
    Xie, RJ
    Sahin, S
    Hammarlund-Udenaes, M
    PHARMACEUTICAL RESEARCH, 2006, 23 (04) : 705 - 717
  • [23] The ABC of the Blood-Brain Barrier - Regulation of Drug Efflux Pumps
    Mahringer, Anne
    Ott, Melanie
    Reimold, Isolde
    Reichel, Valeska
    Fricker, Gert
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (26) : 2762 - 2770
  • [24] Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier
    Kakee, A
    Takanaga, H
    Terasaki, T
    Naito, M
    Tsuruo, T
    Sugiyama, Y
    JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) : 110 - 118
  • [25] The role of efflux transporters in the blood-brain barrier in psychiatric disorders
    de Klerk, O.
    den Boer, J. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S208 - S208
  • [26] Efflux proteins at the blood-brain barrier: review and bioinformatics analysis
    Saidijam, Massoud
    Dermani, Fatemeh Karimi
    Sohrabi, Sareh
    Patching, Simon G.
    XENOBIOTICA, 2018, 48 (05) : 506 - 532
  • [27] Brain mast cell degranulation regulates blood-brain barrier
    Zhuang, X
    Silverman, AJ
    Silver, R
    JOURNAL OF NEUROBIOLOGY, 1996, 31 (04): : 393 - 403
  • [28] Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier
    Zhang, Y
    Pardridge, WM
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) : 168 - 172
  • [29] Recent advances in the brain-to-blood efflux transport across the blood-brain barrier
    Hosoya, K
    Ohtsuki, S
    Terasaki, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 248 (1-2) : 15 - 29
  • [30] Xenobiotic Metabolism and Berry Flavonoid Transport across the Blood-Brain Barrier
    Milbury, Paul E.
    Kalt, Wilhelmina
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (07) : 3950 - 3956